Fagron publishes its annual report 2024 Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2025 –...
Fagron delivers exceptional performance with 14% topline growth and 17% increase in REBITDA for FY 2024 Regulated information – inside...
Fagron solidifies its leadership position with the acquisition of Guinama in Spain Regulated informationNazareth (Belgium)/Rotterdam (The...
Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil Regulated...
Fagron updates on FDA communication regarding the June 2024 inspection at Wichita Regulated information – inside informationNazareth...
Disclosure of notification received from FMR LLC Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM...
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook Regulated information - inside...
Disclosure of notification received from AOC Pharma S.à r.l. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024...
Fagron completes share buy-back program Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 September 2024 – 6PM CET Fagron...
Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET...
Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 30 August 2024 – 6PM CET...
Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 August 2024 – 6PM CET...
Fagron delivers strong performance with 16% topline growth and 17% increase in REBITDA for the first half of 2024 Regulated information - inside...
Fagron shareholders approve all voting items at AGM and EGM Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024...
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting Regulated information Nazareth...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads